BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21917432)

  • 1. IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk.
    Yiannakouris N; Cooper JA; Shah S; Drenos F; Ireland HA; Stephens JW; Li KW; Elkeles R; Godsland IF; Kivimaki M; Hingorani AD; Kumari M; Talmud PJ; Humphries SE
    Nutr Metab Cardiovasc Dis; 2012 Dec; 22(12):1024-30. PubMed ID: 21917432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating 25-hydroxyvitamin D, IRS1 variant rs2943641, and insulin resistance: replication of a gene-nutrient interaction in 4 populations of different ancestries.
    Zheng JS; Parnell LD; Smith CE; Lee YC; Jamal-Allial A; Ma Y; Li D; Tucker KL; Ordovás JM; Lai CQ
    Clin Chem; 2014 Jan; 60(1):186-96. PubMed ID: 24255076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population.
    Tang Y; Han X; Sun X; Lv C; Zhang X; Guo W; Ren Q; Luo Y; Zhang X; Zhou X; Ji L
    Endocrine; 2013 Feb; 43(1):84-91. PubMed ID: 22576021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific interactions between the IRS1 polymorphism and intakes of carbohydrates and fat on incident type 2 diabetes.
    Ericson U; Rukh G; Stojkovic I; Sonestedt E; Gullberg B; Wirfält E; Wallström P; Orho-Melander M
    Am J Clin Nutr; 2013 Jan; 97(1):208-16. PubMed ID: 23221578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IRS1 genetic variants with glucose control and insulin resistance in type 2 diabetic patients from Bosnia and Herzegovina.
    Mahmutovic L; Bego T; Sterner M; Gremsperger G; Ahlqvist E; Velija Asimi Z; Prnjavorac B; Hamad N; Causevic A; Groop L; Semiz S
    Drug Metab Pers Ther; 2019 Mar; 34(1):. PubMed ID: 30888963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population.
    Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D
    Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.
    Rung J; Cauchi S; Albrechtsen A; Shen L; Rocheleau G; Cavalcanti-Proença C; Bacot F; Balkau B; Belisle A; Borch-Johnsen K; Charpentier G; Dina C; Durand E; Elliott P; Hadjadj S; Järvelin MR; Laitinen J; Lauritzen T; Marre M; Mazur A; Meyre D; Montpetit A; Pisinger C; Posner B; Poulsen P; Pouta A; Prentki M; Ribel-Madsen R; Ruokonen A; Sandbaek A; Serre D; Tichet J; Vaxillaire M; Wojtaszewski JF; Vaag A; Hansen T; Polychronakos C; Pedersen O; Froguel P; Sladek R
    Nat Genet; 2009 Oct; 41(10):1110-5. PubMed ID: 19734900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects.
    Sharma R; Prudente S; Andreozzi F; Powers C; Mannino G; Bacci S; Gervino EV; Hauser TH; Succurro E; Mercuri L; Goheen EH; Shah H; Trischitta V; Sesti G; Doria A
    Atherosclerosis; 2011 May; 216(1):157-60. PubMed ID: 21353221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes.
    Caruso M; Ma D; Msallaty Z; Lewis M; Seyoum B; Al-janabi W; Diamond M; Abou-Samra AB; Højlund K; Tagett R; Draghici S; Zhang X; Horowitz JF; Yi Z
    Diabetes; 2014 Jun; 63(6):1933-47. PubMed ID: 24584551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.
    Feng X; Tucker KL; Parnell LD; Shen J; Lee YC; Ordovás JM; Ling WH; Lai CQ
    Asia Pac J Clin Nutr; 2013; 22(1):150-9. PubMed ID: 23353623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits in two populations of different ancestries.
    Zheng JS; Arnett DK; Parnell LD; Smith CE; Li D; Borecki IB; Tucker KL; Ordovás JM; Lai CQ
    Diabetes Care; 2013 Sep; 36(9):2621-7. PubMed ID: 23596181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals.
    Banasik K; Hollensted M; Andersson E; Sparsø T; Sandbaek A; Lauritzen T; Jørgensen T; Witte DR; Pedersen O; Hansen T
    BMC Med Genet; 2012 Feb; 13():10. PubMed ID: 22325233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.
    Prudente S; Di Paola R; Pezzilli S; Garofolo M; Lamacchia O; Filardi T; Mannino GC; Mercuri L; Alberico F; Scarale MG; Sesti G; Morano S; Penno G; Cignarelli M; Copetti M; Trischitta V
    Pharmacogenomics J; 2018 May; 18(3):431-435. PubMed ID: 28696414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between two single-nucleotide polymorphisms (rs1801278 and rs2943641) of insulin receptor substrate 1 gene and type 2 diabetes susceptibility: a meta-analysis.
    Li Q; Qiao Y; Wang C; Zhang G; Zhang X; Xu L
    Endocrine; 2016 Jan; 51(1):52-62. PubMed ID: 26582067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IRS1 rs2943641 variant and risk of future cancer among morbidly obese individuals.
    Maglio C; Ericson U; Burza MA; Mancina RM; Pirazzi C; Assarsson JA; Sjöholm K; Baroni MG; Svensson PA; Montalcini T; Pujia A; Sjöström L; Wiklund O; Carlsson LM; Borén J; Orho-Melander M; Romeo S
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E785-9. PubMed ID: 23418314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants at the endocannabinoid receptor CB1 gene (CNR1) and insulin sensitivity, type 2 diabetes, and coronary heart disease.
    de Miguel-Yanes JM; Manning AK; Shrader P; McAteer JB; Goel A; Hamsten A; ; Fox CS; Florez JC; Dupuis J; Meigs JB
    Obesity (Silver Spring); 2011 Oct; 19(10):2031-7. PubMed ID: 21633404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of branched chain amino acids related variant rs1440581 with risk of incident diabetes and longitudinal changes in insulin resistance in Chinese.
    Xuan L; Hou Y; Wang T; Li M; Zhao Z; Lu J; Xu Y; Chen Y; Qi L; Wang W; Bi Y; Xu M
    Acta Diabetol; 2018 Sep; 55(9):901-908. PubMed ID: 29855804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Gly972Arg polymorphism of IRS1 gene with type 2 diabetes mellitus in lean participants of a national health survey in Mexico: a candidate gene study.
    Burguete-Garcia AI; Cruz-Lopez M; Madrid-Marina V; Lopez-Ridaura R; Hernández-Avila M; Cortina B; Gómez RE; Velasco-Mondragón E
    Metabolism; 2010 Jan; 59(1):38-45. PubMed ID: 19716569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals.
    Bao XY; Peng B; Yang MS
    Mol Biol Rep; 2012 Mar; 39(3):2447-54. PubMed ID: 21643948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between IRS‑1 promoter methylation and type 2 diabetes.
    Ma J; Cheng J; Wang L; Wang H; Xu L; Liu P; Bu S; Zhang L; Le Y; Ye M; Wang Q; Shi Y; Duan S
    Mol Med Rep; 2013 Sep; 8(3):949-53. PubMed ID: 23828647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.